Antiphospholipid syndrome (APS) is a thrombo-inflammatory disease propelled by
circulating autoantibodies that recognize cell surface phospholipids and phospholipid …

Antiphospholipid syndrome is an autoimmune disorder characterized by vascular
thrombosis and/or pregnancy morbidity associated with persistent antiphospholipid antibody …

Women who have had repeated miscarriages often have uncertainties about the cause, the
likelihood of recurrence, the investigations they need, and the treatments that might help …

Background Anticoagulant therapy might reduce the number of miscarriages and adverse
pregnancy outcomes in women with recurrent pregnancy loss and inherited thrombophilia …

Chronic inflammatory placental disorders are a group of rare but devastating gestational
syndromes associated with adverse pregnancy outcome. This review focuses on three …

Around 1–5% of all couples experience recurrent pregnancy loss (RPL). Established risk
factors include anatomical, genetic, endocrine, and hemostatic alterations. With around 50 …

Compared with nonpregnant women, pregnancy carries a four-to fivefold higher risk of
venous thromboembolism (VTE). Despite increasing use of heparin prophylaxis in identified …

Background The co-administration of drugs known to interact greatly impacts morbidity,
mortality, and health economics. This study aims to examine the drug–drug interaction (DDI) …

Although the knowledge of APS pathogenesis has grown in recent years, the management
principles and strategies are largely unchanged. There is an unmet need for evaluating …

STUDY QUESTION In women with threatened miscarriage, does progesterone
supplementation until the completion of the first trimester of pregnancy increase the …